Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
Novo Nordisk A/S
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Novo Nordisk's parent company will buy Catalent to expand Wegovy supply
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
Novo Nordisk Reaches $500 Billion in Market Value as It Points to Growing Demand for Wegovy and Ozempic
Liselotte Sabroe | afp | fake images Novo Nordisk on Wednesday reported better-than-expected profits for 2023 as sales of its…
Norwegian fund says Novo and Eli Lilly could join trillion-dollar club
A pharmacist displays boxes of Ozempic, an injectable semaglutide drug used to treat type 2 diabetes manufactured by Novo Nordisk,…
Merck and J&J CEOs agree to testify at Senate hearing on drug prices
U.S. Senator Bernie Sanders, independent from Vermont, speaks during a People's Action rally, protesting pharmaceutical companies' lobbying against allowing Medicare…
Zepbound is off to a good start, but here's what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…
These four stocks of anti-obesity drugs could skyrocket, says Berenberg
The anti-obesity drug market is expected to remain in the spotlight this year after a bumper 2023 for weight loss…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…